Podcast

Public Health Opportunities in the ED: Step 1: Screen for HBV, Step 2: Link to Care

Launch Date
10/30/2020
Credit Amount
0.00 Expired
Credit Expires
10/30/2021

Faculty

Kris V. Kowdley, MD, FACP, FACG, AGAF, FAASLD
Director, Liver Institute Northwest
Clinical Professor, Elson S. Floyd College of Medicine, Washington State University, Seattle, WA
Kris V. Kowdley, MD, FACP, FACG, AGAF, FAASLD

Dr. Kowdley received his BS in Biology and Anthropology as a member of the Dean’s List at Columbia University, and his medical degree from Mount Sinai School of Medicine. He completed his internship and residency at Oregon Health Science University and a Fellowship in Gastroenterology and Hepatology at Tufts University School of Medicine.

Dr. Kowdley is internationally recognized as a clinician, educator, and researcher in the area of liver disease and has presented his research on liver diseases at more than 165 national and international meetings and scientific symposia. He is the author of over 450 articles, book chapters, reviews, and commentaries in this area, with publications in the Annals of Internal Medicine, Archives of Surgery, Gastroenterology, Hepatology, American Journal of Physiology, and New England Journal of Medicine, among other professional publications.

Dr. Kowdley has extensive experience in clinical trials in all areas of liver disease, including hepatitis C, cholestatic liver disease, primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), nonalcoholic steatohepatitis, and hepatitis B. He has been a principal investigator in several NIDDK-sponsored clinical trials in PBC and PSC and is a member of executive committee of the nonalcoholic steatohepatitis clinical research network (NASH CRN). Dr. Kowdley has also served as the lead investigator of several major international clinical trials in hepatitis C.

Dr. Kowdley’s laboratory program is focused on the role of iron as a co-factor in many liver diseases, including hepatitis C, hemochromatosis, and nonalcoholic steatohepatitis (NASH). He has developed murine models for NASH and is currently exploring the contribution of hepatic iron deposition on the severity of NASH.

Dr. Kowdley’s research program has been continuously funded by the NIDDK since 1999 in addition to several grants from foundations and scientific societies.

Carlos Malvestutto, MD, MPH
Associate Professor
Division of Infectious Diseases
Department of Medicine
The Ohio State University Wexner Medical Center
Columbus, OH
Carlos Malvestutto, MD, MPH

Carlos Malvestutto, MD, MPH is an Associate Professor of Clinical Medicine in the Division of Infectious Diseases at the Ohio State University Wexner Medical Center. Dr. Malvestutto completed his undergraduate degree at Yale University in New Haven, Connecticut and his master’s in public health at Johns Hopkins University Bloomberg School of Public Health in Baltimore, Maryland. He earned his medical degree from the Ponce Health Sciences University in Ponce, Puerto Rico. He then completed his residency in Internal Medicine at Mount Sinai Hospital in New York, New York and his Infectious Disease Fellowship at New York University Medical Center-Tisch Hospital in New York, New York.

Dr. Malvestutto’s research has focused on cardiovascular complications of HIV as well as HIV cure strategies using broadly neutralizing antibodies. He is a member of the HIV Reservoirs and Viral Eradication  (Cure) Transformative Science Group of the AIDS Clinical Trials Group and serves in the Ending the HIV Epidemic Working Group of the HIV Medical Association.

Explore By Section
Statement of Need Learning Objectives Financial Support Target Audience Credit Information Disclosure Declaration Additional Formats

Statement of Need

Screening for hepatitis B virus (HBV) in the emergency department (ED) is an important public health opportunity, as it can reduce transmission in high-risk patients and facilitate linkage to care. HBV testing can be included when screening for sexually transmitted infections (STIs) and hepatitis C virus (HCV), and emergency department (ED) physicians to employ strategies for follow-up, including treatment or vaccination, after receiving HBV results.

The third episode of this CMEOCast podcast series focuses on best practices for screening for HBV in the ED, incorporating the use of interprofessional teams, and fostering patient education for optimal treatment outcomes.

Learning Objectives

At the end of this CME/CE activity, participants should be able to:

  • Identify best practices for screening for HBV in the ED.
  • Facilitate linkage to care when managing patients with HBV in the ED in order to foster patient education and optimal treatment outcomes.

The following learning objectives pertain only to those requesting CNE or CPE credit:

  • Identify best practices for screening for HBV in the ED.
  • Explain how to facilitate linkage to care when managing patients with HBV in the ED in order to foster patient education and optimal treatment outcomes.

Financial Support

Supported by an educational grant from Gilead Sciences, Inc.

Target Audience

Primary care physicians, OB/GYNs, emergency department physicians, PAs, nurse practitioners, and pharmacists.

Credit Information

Physicians (ACCME) 1.0

CME Outfitters, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists/Pharmacy Tech (ACPE) 1.0

This application-based activity is approved for 1.0 contact hour (0.10 CEUs) of continuing pharmacy credit.
Activity UAN: 0376-0000-20-163-H01-P

ABIM MOC 1.0

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Note to Nurse Practitioners

Nurse Practitioners can apply for AMA PRA Category 1 Credit ™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit ™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

Disclosure Declaration

All faculty participating in CME Outfitters continuing education activities are required to disclose any conflict(s) of interest related to the content of their presentation(s) as defined by the ACCME Standards for Commercial Support, and other accrediting and regulatory bodies. Full disclosure of faculty relationships will be made on this website and within the activity course materials prior to the premiere date of this activity.

Additional Formats

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

 

NOTE: Pharmacist CE Universal Activity Number, Enduring: 0376-0000-20-163-H01-P.

PD-037-103020-47

Public Health Opportunities in the ED: Step 1: Screen for HBV, Step 2: Link to Care
Event Date: 10/30/2020